Literature DB >> 31978408

Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases.

Iuliia A Polina1, Daria V Ilatovskaya1, Kristine Y DeLeon-Pennell2.   

Abstract

Release of cell free DNA (cfDNA) from damaged or dead cells routinely occurs in normal physiology. Recently, cfDNA has emerged as an essential biomarker in cardiovascular disease (CVD) of potential prognostic and diagnostic significance. Within the last decade, significant research efforts have been devoted to uncovering the mechanisms mediating cfDNA release and its outcome-predicting ability. The current review focuses on the pathways for cfDNA release in myocardial infarction, heart failure and hypertension, and discusses implementation of cfDNA monitoring to assess the overall development of these disease states and predict future complications. Published by Elsevier B.V.

Entities:  

Keywords:  Cardiovascular disease; Inflammation; MMPs; cfDNA

Mesh：

Substances：

Year:  2020        PMID： 31978408      PMCID： PMC7042038          DOI： 10.1016/j.cca.2020.01.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  76 in total

1.  Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.

Authors:  Y M Dennis Lo; K C Allen Chan; Hao Sun; Eric Z Chen; Peiyong Jiang; Fiona M F Lun; Yama W Zheng; Tak Y Leung; Tze K Lau; Charles R Cantor; Rossa W K Chiu
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

2.  The Impact of Circulating Mitochondrial DNA on Cardiomyocyte Apoptosis and Myocardial Injury After TLR4 Activation in Experimental Autoimmune Myocarditis.

Authors:  Bangwei Wu; Huanchun Ni; Jian Li; Xinyu Zhuang; Jinjin Zhang; Zhiyong Qi; Qiying Chen; Zhichao Wen; Haiming Shi; Xinping Luo; Bo Jin
Journal:  Cell Physiol Biochem       Date:  2017-06-15

3.  Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.

Authors:  Stephanie C Y Yu; K C Allen Chan; Yama W L Zheng; Peiyong Jiang; Gary J W Liao; Hao Sun; Ranjit Akolekar; Tak Y Leung; Attie T J I Go; John M G van Vugt; Ryoko Minekawa; Cees B M Oudejans; Kypros H Nicolaides; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

4.  HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.

Authors:  S Wassmann; U Laufs; A T Bäumer; K Müller; K Ahlbory; W Linz; G Itter; R Rösen; M Böhm; G Nickenig
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

5.  CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling.

Authors:  Kristine Y DeLeon-Pennell; Yuan Tian; Bai Zhang; Courtney A Cates; Rugmani Padmanabhan Iyer; Presley Cannon; Punit Shah; Paul Aiyetan; Ganesh V Halade; Yonggang Ma; Elizabeth Flynn; Zhen Zhang; Yu-Fang Jin; Hui Zhang; Merry L Lindsey
Journal:  Circ Cardiovasc Genet       Date:  2015-11-17

6.  Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta.

Authors:  Adrian Sturza; Matthias S Leisegang; Andrea Babelova; Katrin Schröder; Sebastian Benkhoff; Annemarieke E Loot; Ingrid Fleming; Rainer Schulz; Danina M Muntean; Ralf P Brandes
Journal:  Hypertension       Date:  2013-05-13       Impact factor: 10.190

Review 7.  Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases.

Authors:  Peter Celec; Barbora Vlková; Lucia Lauková; Janka Bábíčková; Peter Boor
Journal:  Expert Rev Mol Med       Date:  2018-01-18       Impact factor: 5.600

8.  Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis.

Authors:  Dandan Yu; Yan Tong; Xinnian Guo; Lingfang Feng; Zhaoqiang Jiang; Shibo Ying; Junlin Jia; Yuan Fang; Min Yu; Hailing Xia; Li Shi; Jianlin Lou
Journal:  Front Oncol       Date:  2019-03-01       Impact factor: 6.244

9.  Considerations and quality controls when analyzing cell-free tumor DNA.

Authors:  Gustav Johansson; Daniel Andersson; Stefan Filges; Junrui Li; Andreas Muth; Tony E Godfrey; Anders Ståhlberg
Journal:  Biomol Detect Quantif       Date:  2019-02-13

10.  Circulating cell-free DNA content as blood based biomarker in endometrial cancer.

Authors:  Lucia Cicchillitti; Giacomo Corrado; Martina De Angeli; Emanuela Mancini; Ermelinda Baiocco; Lodovico Patrizi; Ashanti Zampa; Roberta Merola; Aline Martayan; Laura Conti; Giulia Piaggio; Enrico Vizza
Journal:  Oncotarget       Date:  2017-12-14
View more
  10 in total

1.  Micro-Raman spectroscopy study of blood samples from myocardial infarction patients.

Authors:  Reena V John; Tom Devasia; Mithun N; Jijo Lukose; Santhosh Chidangil
Journal:  Lasers Med Sci       Date:  2022-07-12       Impact factor: 2.555

Review 2.  A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.

Authors:  Amanda G Blouin; Fei Ye; Jenifer Williams; Medhat Askar
Journal:  Hum Immunol       Date:  2021-08-14       Impact factor: 2.211

3.  Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay.

Authors:  David Hsiehchen; Magdalena Espinoza; David E Gerber; Muhammad S Beg
Journal:  Cancer Biol Ther       Date:  2021-08-14       Impact factor: 4.875

Review 4.  The History and Future of Basic and Translational Cell-Free DNA Research at a Glance.

Authors:  Peter B Gahan; Heidi Schwarzenbach; Philippe Anker
Journal:  Diagnostics (Basel)       Date:  2022-05-10

Review 5.  Towards systematic nomenclature for cell-free DNA.

Authors:  Abel J Bronkhorst; Vida Ungerer; Frank Diehl; Philippe Anker; Yuval Dor; Michael Fleischhacker; Peter B Gahan; Lisa Hui; Stefan Holdenrieder; Alain R Thierry
Journal:  Hum Genet       Date:  2020-10-29       Impact factor: 4.132

Review 6.  The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA.

Authors:  Vijay Kumar
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

7.  Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.

Authors:  Sohan Punia; Brian D Juran; Ahmad H Ali; Erik M Schlicht; Raymond M Moore; Zhifu Sun; Konstantinos N Lazaridis
Journal:  BMC Gastroenterol       Date:  2021-04-01       Impact factor: 3.067

8.  Integrated cell-free DNA and cytokine analysis uncovers distinct tissue injury and immune response patterns in solid organ transplant recipients with COVID-19.

Authors:  Temesgen Andargie; Weiqiang Zhou; Andrew Karaba; Taibo Li; Fayaz Seifuddin; Alex Rittenhouse; Hyesik Kong; Komudi Singh; Robert Woodward; Aldo Iacono; Robin Avery; Mehdi Pirooznia; Moon Jang; Hongkai Ji; Andrea Cox; Sean Agbor-Enoh
Journal:  Res Sq       Date:  2022-01-20

9.  Changes in Specific Biomarkers Indicate Cardiac Adaptive and Anti-inflammatory Response of Repeated Recreational SCUBA Diving.

Authors:  Jerka Dumić; Ana Cvetko; Irena Abramović; Sandra Šupraha Goreta; Antonija Perović; Marina Njire Bratičević; Domagoj Kifer; Nino Sinčić; Olga Gornik; Marko Žarak
Journal:  Front Cardiovasc Med       Date:  2022-03-14

10.  Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptoms.

Authors:  Teresa E Daniels; Emily K Zitkovsky; Zachary J Kunicki; Destiny J Price; Abigail L Peterson; Phyllis A Dennery; Hung-Teh Kao; Lawrence H Price; Audrey R Tyrka; Ana M Abrantes
Journal:  Brain Behav Immun Health       Date:  2022-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.